HomepageDHR • NYSE
add
Danaher Corporation
$Â 210,92
Na sluitingstijd:(0,00%)0,00
$Â 210,92
Gesloten: 16 okt, 16:46:01 GMT-4 · USD · NYSE · Disclaimer
Vorige slotkoers
$Â 206,10
Dag-range
$Â 205,48 - $Â 211,59
Jaar-range
$Â 171,00 - $Â 279,41
Beurswaarde
151,03Â mld. USD
Gem. volume
4,51Â mln.
Koers/winst
44,80
Dividendrendement
0,61%
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | jun 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 5,94Â mld. | 3,36% |
Bedrijfskosten | 2,33Â mld. | 3,05% |
Netto inkomsten | 555,00Â mln. | -38,81% |
Netto winstmarge | 9,35 | -40,79% |
Winst per aandeel | 1,80 | 4,65% |
EBITDA | 1,80Â mld. | 3,26% |
Effectief belastingtarief | 15,27% | — |
Balans
Totale activa
Totale passiva
(USD) | jun 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 2,96Â mld. | 24,56% |
Totale activa | 81,62Â mld. | 3,90% |
Totale passiva | 29,28Â mld. | 2,18% |
Totaal aandelenvermogen | 52,34 mld. | — |
Uitstaande aandelen | 716,05 mln. | — |
Koers-boekwaardeverhouding | 2,82 | — |
Rendement op activa | 3,71% | — |
Rendement op kapitaal | 4,28% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | jun 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 555,00Â mln. | -38,81% |
Operationele kasstroom | 1,34Â mld. | -5,58% |
Kasstroom uit beleggingen | -258,00Â mln. | 28,33% |
Kasstroom uit financiering | -247,00Â mln. | 95,68% |
Nettomutatie in liquide middelen | 964,00Â mln. | 120,70% |
Vrije kasstroom | 791,88Â mln. | -30,74% |
Over
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Opgericht
1969
Website
Werknemers
62.000